Screener
Sarepta Therapeutics, Inc. SRPT Amortization Of Discounts Premiums Investments Cash Equivalent And Short Term Investment
Amortization Of Discounts Premiums Investments Cash Equivalent And Short Term Investment at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:AmortizationOfDiscountsPremiumsInvestmentsCashEquivalentAndShortTermInvestment.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | $6,207 | $5,254 | $12,567 | $15,444 |
| Accretion of investment discount, net | 955 | 1,887 | 1,597 | 4,125 |
| Interest expense | (21,508) | (5,228) | (43,221) | (9,731) |
| (Loss) gain on strategic investments | (448) | 36,721 | (2,160) | (54,007) |
| Other, net | (246) | (573) | 918 | (902) |
| Total other (expense) income, net | $(15,040) | $38,061 | $(30,299) | $(45,071) |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s amortization of discounts premiums investments cash equivalent and short term investment?
- Sarepta Therapeutics, Inc. (SRPT) reported amortization of discounts premiums investments cash equivalent and short term investment of $955K in Q2 2026.
- What does amortization of discounts premiums investments cash equivalent and short term investment mean?
- Amortization Of Discounts Premiums Investments Cash Equivalent And Short Term Investment as reported by Sarepta Therapeutics,, Inc. Common Stock.
Ask your AI about Sarepta Therapeutics, Inc.'s amortization of discounts premiums investments cash equivalent and short term investment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude